Spinal Metastases
Conditions
Interventions
Local radiotherapy group:Intensity modulated radiotherapy for local metastatic lesion
Vertebral radiotherapy group:Intensity modulated radiotherapy for metastatic vertebral
Sponsors
Mianyang Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18-80 years; 2) Pathologically confirmed spinal metastatic less than 3 lesions; 3) ECOG score 0-1; KPS =60; 4) without severe hypertension, diabetes, heart disease and so on; 5) There was no contraindication of radiotherapy; Vertebral metastasis in this trail has not received radiotherapy in the past; 6) The estimated survival time is more than 3 months; 7) Patients or family members signed the informed consent; 8) Patients has good compliance with treatment and agreed to cooperate for survival follow-up.
Exclusion criteria
Exclusion criteria: 1) Benign diseases leading to bone destruction; 2) Multiple myeloma and lymphoma and leukemia; 3) Pregnant or lactating women; 4) Patients who underwent radiotherapy or vertebral surgery prior Over the past four weeks to the start of this trial; 5) Severe hypertension, diabetes and heart disease; 6) Severe neurological or psychiatric disorders, including dementia and epileptic seizures; 7) Patients with abnormal coagulation function and risk of fatal massive hemorrhage; 8) Serious adverse reactions are known to occur at any stage of treatment; 9) Those who have participated in other clinical trials in the past four weeks; 10) Researchers believe that some obvious diseases should be excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain-relieving rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of side effects; | — |
Countries
China
Contacts
Public ContactYuan Li
Mianyang Central Hospital
Outcome results
None listed